Navigation Links
REGiMMUNE to present GvHD data at the 50th ASH Annual Meeting
Date:12/5/2008

Mountain View, CA December 5, 2008 REGiMMUNE Corporation, a privately held biopharmaceutical company focused on developing technologies and products for immune disorders, will present preclinical data on the company's potential therapeutic treatment for Graft versus Host Disease (GvHD) at the American Society of Hematology Annual Meeting being held December 6 through 9 in San Francisco, California. REGiMMUNE is developing KRN7000 (RGI-2001) as a new immunosuppressant for GvHD associated with stem cell transplantation. Two posters will be presented at ASH on the evenings of Sunday December 7 and Monday December 8, respectively.

Abstract/Poster II-426
Sunday, December 7: 6:00 PM - 8:00 PM
Donor-Specific Tolerance Induction through Expansion of DCregs and Tregs by a Liposomal Formulation of KRN7000 (RGI-2001)

Abstract/Poster III-582
Monday, December 8: 5:30 PM - 7:30 PM
A Liposomal Formulation of KRN7000 (RGI-2001) Potently Reduces GvHD Lethality through the Expansion of CD4+Foxp3+ Regulatory T cells in Murine Models.

"We are delighted to present our progress on RGI-2001 development at the 50th ASH Annual Meeting," said Mr. Haru Morita, President and Chief Executive Officer, REGiMMUNE. "This is a great opportunity to provide an update on our pre-IND stage product candidate, RGI-2001, which is in a preclinical study for GvHD associated with bone marrow transplantation. The company is also developing RGI-2001 for solid organ transplantation. Our mission is to develop novel therapies for immune disorders including allergies, autoimmune diseases and transplantation. We believe the success of RGI-2001 will be the first demonstration of the promise of our proprietary technology and of the company's significant development capabilities."


'/>"/>

Contact: Debra Bannister
530-676-8001
REGiMMUNE
Source:Eurekalert

Page: 1

Related medicine news :

1. 11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions
2. Aflac Incorporated To Present at the Goldman Sachs U.S. Financial Services Conference 2008
3. Inverness Medical Innovations to Present at RBC Capital Markets 2008 Healthcare Conference on December 11, 2008
4. MaxCyte to Present Targeted Cancer Immunotherapy Product at 50th Annual Meeting of the American Society of Hematology
5. Zevalin Data to be Presented at ASH 2008
6. MAP Pharmaceuticals to Present at the 2008 RBC Capital Markets Healthcare Conference
7. Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis
8. Cardium Announces Investor Presentation and Corporate Update Webcast
9. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented at American Society of Hematology Annual Meeting
10. LCA-Vision to Present at RBC Capital Markets 2008 Healthcare Conference
11. Quark Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2014)... Floor-grade instrument buyers ... of 5. This above-average score represents favorable conditions ... negotiation power over the three years to 2014. ... the period, surging demand for healthcare services and ... product development, have placed upward pressure on the ...
(Date:7/11/2014)... 2014 Recently, MagicQuinceaneraDresses.com, the popular online ... collection of 2014 Quinceanera dresses . The company’s ... to look fashionable without paying a large amount of ... to 57% off. , The company’s online shop has ... amazing special occasion outfits. In addition to exquisite Quinceanera ...
(Date:7/11/2014)... Ticket Down reports that tickets to the ... place World Cup Match between Brazil and Netherlands ... place on Saturday, July 12th at Estadio Nacional de Brasilia ... take place on Sunday, July 13th at Estadio Jornalista Mario ... for the 2014 World Cup are guaranteed to be authentic ...
(Date:7/11/2014)... FRIDAY, July 11, 2014 (HealthDay News) -- People with the ... condition called peripheral artery disease (PAD), a new study suggests. ... supply blood to the limbs, most often the legs. The ... narrowing of the arteries throughout the body. People with PAD ... Researchers analyzed data from nearly 6,800 people with PAD who ...
(Date:7/11/2014)... As part of its morcellator ... has been closely monitoring the ongoing meeting of ... Obstetrics and Gynecology Devices Panel, which has been ... risks associated with the use of power morcellators ... report published by Dow Jones Business News, a ...
Breaking Medicine News(10 mins):Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Cheap Quinceanera Dresses Now Available At MagicQuinceaneraDresses.com 2Health News:Argentina vs. Germany World Cup Finals Tickets & Brazil vs. Netherlands 3rd Place World Cup Tickets Are in Huge Demand 2Health News:Poor More Prone to Leg Circulation Trouble 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 4
... Surgical Company (Nasdaq: STAA ), a developer, manufacturer ... announced the completion of a registered direct offering of 4,255,319 ... per share, which was the closing market price on June ... million because the Company did not use an underwriter for ...
... & rescue manager won contest to clone beloved pet Trakr, hero ... Can you clone a hero? ... rescue dog and 9-11 hero, Trakr, will receive five answers to ... California biotech company that is offering the first commercial dog cloning ...
... ... that it is taking sign-ups for this year,s annual subtle energies and healing conference. ... is called "Sacred Synthesis: Science with Heart". , ... Denver, CO (PRWEB) June 17, 2009 -- ISSSEEM (International ...
... ... of the clinical study that was performed using the Bariatric Advantage High Protein Meal ... Obesity (ECO). , ... Amsterdam, Holland (Vocus) June 17, 2009 -- Bariatric Advantage presented the results of the ...
... ... Remote Control 4.0. It allows help desk staff to administer and remotely control ... easy to find computers With its unique search engine. It can find the ... http://www.intelliadmin.com/blog/index.php/2009/06/remote-control-40-beta-rc4-and-usb-disabler-pro/ , ...
... ... of the University of Oklahoma, OU Physicians has established a standard of efficient patient centered ... facility was designed to consolidate the private practices for physicians teaching at the University of ... ...
Cached Medicine News:Health News:STAAR Surgical Completes Common Stock Offering 2Health News:STAAR Surgical Completes Common Stock Offering 3Health News:BioArts International Clones 9-11 Hero Dog - Owner to Receive Five Cloned Puppies June 17 in Los Angeles 2Health News:BioArts International Clones 9-11 Hero Dog - Owner to Receive Five Cloned Puppies June 17 in Los Angeles 3Health News:2009 ISSSEEM Conference to Have Deepak Chopra Discuss Bridging Science and Spirit 2Health News:2009 ISSSEEM Conference to Have Deepak Chopra Discuss Bridging Science and Spirit 3Health News:Bariatric Advantage High Protein Meal Replacement Clinical Study Presented at European Congress on Obesity 2Health News:Windows 7 Compatible Remote Desktop Software Released (Beta 4) 2
(Date:7/10/2014)... , July 10, 2014  Decision Resources ... surveyed infectious disease (ID) specialists are willing to ... Orbactiv (oritavancin) for use as OPAT, approximately two-thirds ... these agents to their hospital inpatients. However, our ... OPAT patients are initiated on OPAT following hospital ...
(Date:1/15/2014)... , Jan. 15, 2014 Sono-Tek Corporation (OTC BB: ... ended November 30, 2013, compared to sales of $2,202,000 for ... Once again, this quarter has also shown growth over the ... first quarter of this fiscal year. Markets that experienced sales ...
(Date:1/15/2014)... GRAND RAPIDS, Mich. , Jan. 15, 2014 As ... of the flu virus, select Meijer pharmacies in ... and strep throat to eligible patients, enabling Meijer pharmacists to ... under strict protocol set by a physician participating in the ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... ATLANTA, Oct. 13, 2011 Anesthesiologists are quickly turning ... cost-effective, high quality care.  An annual survey of anesthesia ... of survey respondents indicating that IT solutions are a ... key driver in IT decisions.  The survey of 212 ...
... 13, 2011 Cumberland Pharmaceuticals Inc. ... release third quarter 2011 financial results after the market closes ... Internet webcast will be held on Thursday, November 3, 2011, ... To participate in the call, please dial 877-303-1298 (for ...
Cached Medicine Technology:Annual Survey Demonstrates Increased Demand for Anesthesia Information Management Systems 2Annual Survey Demonstrates Increased Demand for Anesthesia Information Management Systems 3
EC+ Extra Care Bariatric Bed...
... system is a unique healthcare ... dual width capability with a ... design. Specifically developed to accommodate ... the easy-to-use Tri-Flex I system ...
... Nebulizer W/ 7` CR Resistant Oxygen Tubing., ... treatment times , ,Provide fine particles ... respirable particles) than conventional nebulizers, ,Our ... deliver fast and effective treatment more efficiently ...
... Nebulizer Disposable Prefilled 28%-100% FIO 2 1000ML ... ,Our prefilled nebulizers provide unmatched performance and ... cool high-output aerosols adjustable from 28% to 100% ... of solutions: sterile water for inhalation, USP; 0.45% ...
Medicine Products: